{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:42Z","timestamp":1707524802286},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,20]]},"DOI":"10.7759\/cureus.31697","type":"journal-article","created":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T17:37:30Z","timestamp":1668965850000},"source":"Crossref","is-referenced-by-count":0,"title":["Systemic Bacillus Calmette-Guerin Infection One Year After Intravesical Immunotherapy Mimicking Sarcoidosis"],"prefix":"10.7759","author":[{"given":"Yashswee","family":"Kc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail E","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009726","article-title":"Bone marrow granulomas in a high tuberculosis prevalence setting: a clinicopathological study of 110 cases","volume":"97","author":"Wang Y","year":"2018","unstructured":"Wang Y, Tang XY, Yuan J, et al.. Bone marrow granulomas in a high tuberculosis prevalence setting: a clinicopathological study of 110 cases. Medicine (Baltimore). 2018, 97:e9726. 10.1097\/MD.0000000000009726","journal-title":"Medicine (Baltimore)"},{"key":"ref2","article-title":"Differential diagnoses of bone marrow granuloma","volume":"164","author":"Eid A","year":"1996","unstructured":"Eid A, Carion W, Nystrom JS. Differential diagnoses of bone marrow granuloma. West J Med. 1996, 164:510-5.","journal-title":"West J Med"},{"key":"ref3","article-title":"The combating of tuberculosis in the light of the experience that has been gained in the successful combating of other infectious diseases","volume":"16","author":"Med-Rath G","year":"2007","unstructured":"Med-Rath G, Koch R. The combating of tuberculosis in the light of the experience that has been gained in the successful combating of other infectious diseases. J Laryngol Otol. 2007, 16:187-91.","journal-title":"J Laryngol Otol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update","volume":"9","author":"Guallar-Garrido S","year":"2020","unstructured":"Guallar-Garrido S, Juli\u00e1n E. Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update. Immunotargets Ther. 2020, 9:1-11. 10.2147\/ITT.S202006","journal-title":"Immunotargets Ther"},{"key":"ref5","article-title":"History of BCG vaccine","volume":"8","author":"Luca S","year":"2013","unstructured":"Luca S, Mihaescu T. History of BCG vaccine. Maedica (Bucur). 2013, 8:53-8.","journal-title":"Maedica (Bucur)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6230409","article-title":"Clinical spectrum of complications induced by intravesical immunotherapy of Bacillus Calmette-Gu\u00e9rin for bladder cancer","volume":"2019","author":"Liu Y","year":"2019","unstructured":"Liu Y, Lu J, Huang Y, Ma L. Clinical spectrum of complications induced by intravesical immunotherapy of Bacillus Calmette-Gu\u00e9rin for bladder cancer. J Oncol. 2019, 2019:6230409. 10.1155\/2019\/6230409","journal-title":"J Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016771","article-title":"Immune adjuvant therapy using Bacillus Calmette-Gu\u00e9rin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments","volume":"98","author":"Nishida S","year":"2019","unstructured":"Nishida S, Tsuboi A, Tanemura A, et al.. Immune adjuvant therapy using Bacillus Calmette-Gu\u00e9rin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Medicine (Baltimore). 2019, 98:e16771. 10.1097\/MD.0000000000016771","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13475","article-title":"A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Gu\u00e9rin therapy for superficial urinary bladder cancer","volume":"47","author":"Robinson AR","year":"2017","unstructured":"Robinson AR, Radhakrishnan R, Horvath R, Pandey S. A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Gu\u00e9rin therapy for superficial urinary bladder cancer. Intern Med J. 2017, 47:820-3. 10.1111\/imj.13475","journal-title":"Intern Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4136-9","article-title":"The first case of bacillus Calmette-Gu\u00e9rin-induced small-vessel central nervous system vasculitis","volume":"37","author":"Parent ME","year":"2018","unstructured":"Parent ME, Richer M, Liang P. The first case of bacillus Calmette-Gu\u00e9rin-induced small-vessel central nervous system vasculitis. Clin Rheumatol. 2018, 37:2297-302. 10.1007\/s10067-018-4136-9","journal-title":"Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm DL","year":"1992","unstructured":"Lamm DL, van der Meijden PM, Morales A, et al.. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992, 147:596-600. 10.1016\/s0022-5347(17)37316-0","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(99)00591-9","article-title":"Long-term results of intravesical Bacillus Calmette-Gu\u00e9rin therapy for stage T1 superficial bladder cancer","volume":"55","author":"Brake M","year":"2000","unstructured":"Brake M, Loertzer H, Horsch R, et al.. Long-term results of intravesical Bacillus Calmette-Gu\u00e9rin therapy for stage T1 superficial bladder cancer. Urology. 2000, 55:673-8. 10.1016\/s0090-4295(99)00591-9","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcps0706711","article-title":"Clinical problem-solving. An unintended consequence--a 79-year-old man with a 5-month history of fatigue and 20-lb (9-kg) weight loss presented to his local physician","volume":"358","author":"Safdar N","year":"2008","unstructured":"Safdar N, Abad CL, Kaul DR, Jarrard D, Saint S. Clinical problem-solving. An unintended consequence--a 79-year-old man with a 5-month history of fatigue and 20-lb (9-kg) weight loss presented to his local physician. N Engl J Med. 2008, 358:1496-501. 10.1056\/NEJMcps0706711","journal-title":"N Engl J Med"},{"key":"ref13","article-title":"Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis","volume":"3","author":"Adams JS","year":"1986","unstructured":"Adams JS, Gacad MA, Anders A, Endres DB, Sharma OP. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis. Sarcoidosis. 1986, 3:1-6.","journal-title":"Sarcoidosis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113951-systemic-bacillus-calmette-guerin-infection-one-year-after-intravesical-immunotherapy-mimicking-sarcoidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:56Z","timestamp":1707508136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113951-systemic-bacillus-calmette-guerin-infection-one-year-after-intravesical-immunotherapy-mimicking-sarcoidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,20]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.31697","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,20]]}}}